Genzyme confirms details of consent decree and $175m fine
May 27, 2010Manufacturing and Production Cerezyme, Fabrazyme, Genzyme, Lumizyme, Thyrogen, manufacturing compliance
Genzyme’s predictions on the penalties levied for the ongoing problems at its manufacturing facility in Allston Landing have been confirmed, …
FDA approves Genzyme’s Lumizyme
May 27, 2010Sales and Marketing Genzyme, Lumizyme, Myozyme, Pompe disease
US biotech Genzyme is celebrating FDA approval of its late-onset treatment for Pompe disease Lumizyme. The green light to market …
Roche forms translational medicine research hub
May 26, 2010Research and Development Roche, Switzerland, academic research, translational
Roche is linking up with Basel’s university and university hospital in a ‘strategic alliance’ that will establish and manage what …
NICE rejects Bayer’s liver cancer drug
May 26, 2010Sales and Marketing NICE, Nexavar, patient access scheme
Bayer’s liver cancer drug Nexavar has been rejected by NICE after it deemed the drug too costly for a marginal …
Full steam ahead for NHS boards
May 26, 2010Monitor, NHS, government
The government is setting up new NHS boards that will act independently to allocate resources and oversee the commissioning of …
Abbott starts head-to-head MS trial
May 25, 2010Research and Development, Sales and Marketing Abbott, Avonex, Biogen, Gilena, daclizumab
Abbott has started enrolment for a phase III trial of daclizumab, a once-monthly injection for relapsing-remitting multiple sclerosis that it …
European green light for Allergan’s Ozurdex
May 25, 2010Sales and Marketing Allergan, CHMP, Ozurdex, macular oedema
European authorities have given the green light for Ozurdex, a treatment for adults with a potentially serious eye disease. Ozurdex …
Takeda appoints Kiyohiko Tamura
May 25, 2010Sales and Marketing Takeda, appointment, sales and marketing
Japanese pharma company Takeda has appointed Kiyohiko Tamura general manager of its newly established Office of the President & CEO. …
MMR doctor struck off
May 25, 2010GMC, MMR
The doctor at the centre of a 12-year MMR vaccine debate has been struck off the medical register after being …
Kaiser Permanente unit joins Quintiles ‘Prime Site’ network
May 25, 2010Research and Development CRO, Kaiser Permanente, Quintiles
A unit of US health maintenance organisation Kaiser Permanente has become the fourth in Quintiles’ network of ‘Prime Sites’ – …
Lucentis boosted by diabetic vision study
May 24, 2010Research and Development, Sales and Marketing AMD, DME, Lucentis, Novartis
A phase III trial of Novartis’ ranibizumab has shown it to be superior at promoting vision gain in patients with …
Boehringer selects lead candidate for Alzheimer’s
May 24, 2010Research and Development Ablynx, Boehringer
Boehringer Ingelheim has selected a lead candidate for further development to treat Alzheimer’s disease from its collaboration with Ablynx. Belgium-based …
Eisai opens $100m parenterals plant in North Carolina
May 24, 2010Manufacturing and Production, Research and Development Aricept, Eisai, eribulin, parenterals
Japanese drugmaker Eisai has opened a 65,000-sq.ft. facility at Research Triangle Park in North Carolina, USA, which will serve as …
First artificial life created
May 24, 2010Research and Development Cell biology, Venter, cell, genome
Scientists in the US have succeeded in developing the first living cell to be controlled entirely by synthetic DNA. The …
Pharma manufacturing news in brief
May 24, 2010Manufacturing and Production Angel Biotech, Halozyme, Johnson Matthey, Ranbaxy, Sagent Pharmaceuticals, baxter
There are more quality problems to report on the manufacturing beat this week, with recalls for Ranbaxy, Halozyme/Baxter and Sagent …
Asda cuts cancer drugs prices
May 24, 2010Sales and Marketing Asda, Cancer, market access, price cuts, pricing, supermarket
UK supermarket chain Asda has started selling privately prescribed cancer drugs on a not-for-profit basis. The vast majority of drugs …
Turkey: volatility and growth
May 24, 2010Sales and Marketing Turkey, em
The economic woes of Greece are currently the most worrying problem within the European Union’s single currency region the Eurozone, …
German patent setback for GlaxoSmithKline’s Seretide
May 21, 2010Sales and Marketing GSK, Germany, Seretide
A Munich court has ruled GlaxoSmithKline’s combination patent for its asthma and COPD treatment Seretide is not valid. The Federal …
Digital Pharma: Doctors.net.uk’s Nordic expansion
May 21, 2010Medical Communications, Sales and Marketing community, digital pharma, doctors.net, meduniverse
UK online doctors network Doctors.net.uk has taken a stake in its Swedish counterpart MedUniverse as part of international expansion plans. …
Abbott poised to take top spot in India
May 21, 2010Sales and Marketing Abbott, India, Piramal, em
Abbott has acquired Indian firm Piramal’s Healthcare Solutions business in a deal that is set to make it the number …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
